My backgound briefly (full details in Profile): aggressive form, BRCA2 mutation, RP in 2017, then 39 sessions of radiation, and 3 yrs of Lupron. All at Smilow Cancer Hospital.
As a result, my PSA was undetectable for 2.5 years, and in 9/21 I was put on a "vacation" from treatment.
Then PSA started to rise: 2/28/22 0.03, 4/5/22 0.06, 6/7/22 0.13, 8/8/22 0.26, 10/25/22 0.50, 11/29/22 0.55, 12/24/23 0.72, 3/27/23 0.78.
PET PSMA scan on 1/21/23 showed a "small (0.6 cm)" nodule in upper left lung. It was targeted with 4 doses of radiation in 4/23 and PSA decreased for a while: 5/17/23 0.61, 7/31/23 0.39, then began to rise: 9/28/23 0.55, 11/10/23 1.22.
I had another PET PSMA scan on 12/1/23, which showed that the lung nodule had resolved, but that there was a “new small radiotracer avid mediastinal lymph node, compatible with metastatic disease.” (Report did not indicate size or which mediastinal lymph node.)
The Q now is what to do? I will meet with my oncologist on 12/5/23 and, as I understand it from discussions prior to the last scan, there are, in principle, 3 possible ways to proceed: (1) wait, test for PSA, and watch what happens, hoping for a plateau; (2) radiate the new metastasis(ses); (3) begin doublet or triplet therapy.
My guess now is that (1) is not wise given that metastases keep appearing; and I don’t know if (2) is feasible because of the location near trachea, heart, spine, etc. My inclination is always toward aggressive treatment, but now that there is a scan result, I will find out on 12/5.
I’m 76 and my health otherwise is good—I exercise a lot, eat healthfully, lost a decent amount of excess weight this year, travel, have a wonderfully supportive wife and family, am keeping productively busy. The AUS I got at MSK two years ago continues to work and was/is a life changer.
Thanks for reading, and I welcome any comments.